These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 16396699

  • 1. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z, Malaise M, Nekam K, Koó E, Dankó K, Kovacs M, Scarpignato C.
    Clin Exp Rheumatol; 2005; 23(6):809-18. PubMed ID: 16396699
    [Abstract] [Full Text] [Related]

  • 2. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.
    Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596
    [Abstract] [Full Text] [Related]

  • 3. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Deeks JJ, Smith LA, Bradley MD.
    BMJ; 2002 Sep 21; 325(7365):619. PubMed ID: 12242171
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.
    JAMA; 1999 Nov 24; 282(20):1921-8. PubMed ID: 10580457
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D, Hughes K, Harris S, Shakir SA.
    Rheumatology (Oxford); 2003 Nov 24; 42(11):1332-41. PubMed ID: 12810929
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL.
    Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563
    [Abstract] [Full Text] [Related]

  • 7. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis.
    Montrone F, Santandrea S, Caruso I, Gerli R, Cesarotti ME, Frediani P, Bassani R.
    J Int Med Res; 2000 Jul 17; 28(2):91-100. PubMed ID: 10898121
    [Abstract] [Full Text] [Related]

  • 8. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
    Lazzaroni M, Anderloni A, Bianchi Porro G.
    Eur J Gastroenterol Hepatol; 2001 Jul 17; 13(7):833-9. PubMed ID: 11474314
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar 17; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 10. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr 17; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 11. Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents.
    You JH, Lee KK, Chan TY, Lau WH, Chan FK.
    Aliment Pharmacol Ther; 2002 Dec 17; 16(12):2089-96. PubMed ID: 12452942
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
    Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS.
    Lancet; 2002 Dec 17; 354(9196):2106-11. PubMed ID: 10609815
    [Abstract] [Full Text] [Related]

  • 13. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
    Hsiang KW, Chen TS, Lin HY, Luo JC, Lu CL, Lin HC, Lee KC, Chang FY, Lee SD.
    Clin Ther; 2010 Jul 17; 32(7):1294-303. PubMed ID: 20678677
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Kellner HL, Li C, Essex MN.
    Curr Med Res Opin; 2012 Sep 17; 28(9):1537-45. PubMed ID: 22852870
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.
    Mallen SR, Essex MN, Zhang R.
    Curr Med Res Opin; 2011 Jul 17; 27(7):1359-66. PubMed ID: 21561397
    [Abstract] [Full Text] [Related]

  • 16. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Jul 17; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

  • 17. Potential antioxidant activity of celecoxib and amtolmetin guacyl: in vitro studies.
    Kirkova M, Alexandova A, Kesiova M, Tsvetanova E, Georgieva A, Todorov S.
    Auton Autacoid Pharmacol; 2007 Jan 17; 27(1):13-8. PubMed ID: 17199871
    [Abstract] [Full Text] [Related]

  • 18. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
    Kirkova M, Alexandova A, Kesiova M, Todorov S.
    Auton Autacoid Pharmacol; 2007 Apr 17; 27(2):99-104. PubMed ID: 17391279
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis].
    Biasi G, Marcolongo R.
    Minerva Med; 2001 Oct 17; 92(5):315-24. PubMed ID: 11675575
    [Abstract] [Full Text] [Related]

  • 20. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov 17; 38(11):81-6. PubMed ID: 11138599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.